Your browser is no longer supported. Please, upgrade your browser.
CTMX CytomX Therapeutics, Inc. daily Stock Chart
CTMX [NASD]
CytomX Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.25 Insider Own0.20% Shs Outstand45.33M Perf Week18.27%
Market Cap340.43M Forward P/E- EPS next Y-2.45 Insider Trans0.00% Shs Float41.18M Perf Month5.77%
Income-102.20M PEG- EPS next Q-0.46 Inst Own87.90% Short Float3.46% Perf Quarter-5.06%
Sales57.50M P/S5.92 EPS this Y-11.10% Inst Trans6.56% Short Ratio3.16 Perf Half Y0.81%
Book/sh1.12 P/B6.71 EPS next Y-11.40% ROA-26.20% Target Price13.82 Perf Year-32.52%
Cash/sh6.53 P/C1.15 EPS next 5Y-0.90% ROE-114.50% 52W Range3.60 - 12.63 Perf YTD-9.63%
Dividend- P/FCF- EPS past 5Y-17.70% ROI-216.20% 52W High-40.54% Beta0.42
Dividend %- Quick Ratio3.50 Sales past 5Y62.50% Gross Margin- 52W Low108.90% ATR0.74
Employees158 Current Ratio3.50 Sales Q/Q-27.80% Oper. Margin- RSI (14)59.57 Volatility9.34% 13.32%
OptionableYes Debt/Eq0.00 EPS Q/Q-9.10% Profit Margin- Rel Volume1.05 Prev Close7.47
ShortableYes LT Debt/Eq0.00 EarningsFeb 27 AMC Payout- Avg Volume450.89K Price7.51
Recom1.90 SMA2027.15% SMA5011.04% SMA200-5.90% Volume475,230 Change0.54%
Mar-24-20Upgrade Wedbush Neutral → Outperform
Mar-04-20Initiated Barclays Equal Weight $7
Nov-20-19Initiated Guggenheim Buy
Nov-11-19Downgrade Wedbush Outperform → Neutral $25 → $8
Jun-13-19Initiated Mizuho Buy
May-14-19Initiated Cantor Fitzgerald Overweight $21
Mar-11-19Initiated Barclays Overweight $16
Nov-26-18Initiated Piper Jaffray Overweight $22
Oct-15-18Initiated Goldman Neutral $21
Sep-13-18Initiated H.C. Wainwright Buy $32
Jun-01-18Initiated SunTrust Buy $38
Jan-05-18Initiated Citigroup Buy $40
Sep-08-17Initiated Wedbush Outperform $26
Mar-27-17Initiated H.C. Wainwright Buy $24
Mar-02-17Initiated Instinet Buy $21
Jan-03-17Downgrade Oppenheimer Outperform → Perform
Nov-02-15Initiated Oppenheimer Outperform $17
Nov-02-15Initiated Jefferies Buy $19
Nov-02-15Initiated BofA/Merrill Buy
Apr-03-20 12:00PM  CytomX Therapeutics (CTMX) Upgraded to Buy: Here's What You Should Know Zacks
11:37AM  Will CytomX Therapeutics Continue to Surge Higher? Zacks
09:37AM  Top Ranked Momentum Stocks to Buy for April 3rd Zacks
Mar-31-20 08:26AM  The Daily Biotech Pulse: Amarin Faces Legal Setback, Milestone Payment Kicks In For CytomX, Savara, Reata Disclose COVID-19 Disruptions Benzinga +14.48%
Mar-30-20 04:15PM  CytomX Therapeutics Announces Milestone Achievement in AbbVie CD71 Partnership and Provides Update on Impact of COVID-19 on Clinical Stage Pipeline GlobeNewswire +5.51%
Mar-25-20 04:02PM  CytomX Therapeutics Announces New Employment Inducement Grant GlobeNewswire
10:13AM  CytomX & Astellas Collaborate to Develop Novel Cancer Therapy Zacks
Mar-24-20 05:35PM  Peninsula biotech scores $80M upfront in potential $1.6 billion cancer drug deal American City Business Journals +32.45%
08:20AM  The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test Benzinga
Mar-23-20 08:00PM  CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop Probody® T-Cell Engaging Bispecific Therapies for Treatment of Cancer GlobeNewswire
04:02PM  CYTOMX THERAPEUTICS ANNOUNCES APPOINTMENT OF CARLOS CAMPOY AS CHIEF FINANCIAL OFFICER GlobeNewswire
Mar-16-20 04:23PM  CytomX Therapeutics Announces New Employment Inducement Grant GlobeNewswire -30.17%
Mar-11-20 03:39PM  Edited Transcript of CTMX earnings conference call or presentation 27-Feb-20 10:00pm GMT Thomson Reuters StreetEvents -9.13%
Feb-29-20 08:34AM  CytomX Therapeutics, Inc. Consensus Forecasts Have Become A Little Darker Since Its Latest Report Simply Wall St.
Feb-27-20 05:45PM  CytomX Therapeutics (CTMX) Reports Q4 Loss, Lags Revenue Estimates Zacks
04:28PM  CytomX Therapeutics Announces Full-Year 2019 Financial Results and Provides Business Update GlobeNewswire
12:00PM  CytomX Therapeutics (CTMX) Upgraded to Buy: What Does It Mean for the Stock? Zacks
Feb-25-20 08:00AM  CytomX Therapeutics to Present at Cowen and Company 40th Annual Health Care Conference GlobeNewswire
Feb-24-20 08:00AM  Bristol-Myers Squibb Advances CytomX Therapeutics Anti-CTLA-4 Probody Therapeutic BMS-986249 into Randomized Cohort Expansion (Part 2a) of Ongoing Clinical Trial GlobeNewswire
Feb-20-20 08:00AM  CytomX Therapeutics to Announce Fourth Quarter 2019 Financial Results GlobeNewswire
Feb-19-20 12:31PM  Will CytomX Therapeutics (CTMX) Report Negative Q4 Earnings? What You Should Know Zacks
Feb-07-20 04:02PM  CytomX Therapeutics Announces New Employment Inducement Grant GlobeNewswire -9.15%
Feb-05-20 11:52AM  Steven Cohen Renews His Interest in Verastem GuruFocus.com
Feb-03-20 08:00AM  CytomX Therapeutics Appoints Alison L. Hannah, M.D. as Chief Medical Officer GlobeNewswire
Jan-17-20 04:10PM  CytomX Therapeutics Announces New Employment Inducement Grants GlobeNewswire
Dec-31-19 09:07AM  The CytomX Therapeutics (NASDAQ:CTMX) Share Price Is Down 45% So Some Shareholders Are Getting Worried Simply Wall St.
Dec-19-19 08:03AM  CytomX Therapeutics Provides Updates on Lead Clinical Programs and 2020 Portfolio Outlook GlobeNewswire +8.98%
Dec-17-19 04:03PM  CytomX Therapeutics Announces New Employment Inducement Grants GlobeNewswire
Dec-09-19 01:10PM  Hedge Funds Have Never Been More Bullish On CytomX Therapeutics, Inc. (CTMX) Insider Monkey
Dec-06-19 04:06PM  CytomX Therapeutics Announces New Employment Inducement Grants GlobeNewswire
Nov-26-19 09:56PM  Edited Transcript of CTMX earnings conference call or presentation 7-Nov-19 10:00pm GMT Thomson Reuters StreetEvents
Nov-11-19 11:55AM  Wedbush Downgrades CytomX Due To Lack Of Clarity On Development Paths Benzinga -6.05%
08:00AM  CytomX Therapeutics to Present at Upcoming Healthcare Conferences GlobeNewswire
Nov-07-19 04:09PM  CytomX Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
Oct-31-19 10:34AM  Will CytomX Therapeutics (CTMX) Report Negative Earnings Next Week? What You Should Know Zacks
Oct-30-19 05:23PM  CytomX Therapeutics, Inc. (CTMX) Is Burning These Hedge Funds Insider Monkey
Oct-29-19 04:04PM  CytomX Therapeutics Announces Initiation of Phase 2 Clinical Trial Evaluating the Anti-PD-L1 Probody CX-072 in Combination with YERVOY® in Patients with Relapsed or Refractory Melanoma GlobeNewswire -5.52%
Oct-24-19 08:00AM  CytomX Therapeutics to Announce Third Quarter 2019 Financial Results GlobeNewswire -6.91%
Oct-18-19 04:05PM  CytomX Therapeutics Announces New Employment Inducement Grants GlobeNewswire -5.62%
Oct-14-19 08:00AM  CytomX Therapeutics Announces Appointment of Amy C. Peterson, M.D. as Chief Development Officer GlobeNewswire
Sep-21-19 10:20AM  Will CytomX Therapeutics (NASDAQ:CTMX) Spend Its Cash Wisely? Simply Wall St.
Aug-28-19 08:00AM  CytomX Therapeutics to Present at Upcoming Healthcare Conferences GlobeNewswire
Aug-16-19 02:22PM  Did CytomX Therapeutics, Inc. (NASDAQ:CTMX) Insiders Buy Up More Shares? Simply Wall St.
12:00AM  Edited Transcript of CTMX earnings conference call or presentation 7-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Aug-08-19 12:37AM  CytomX Therapeutics, Inc. (CTMX) Q2 2019 Earnings Call Transcript Motley Fool
Aug-07-19 07:05PM  CytomX Therapeutics (CTMX) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:10PM  CytomX Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
Aug-06-19 08:00AM  CytomX Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference GlobeNewswire +8.35%
Jul-31-19 10:36AM  Earnings Preview: CytomX Therapeutics (CTMX) Q2 Earnings Expected to Decline Zacks
Jul-30-19 08:00AM  CytomX Therapeutics to Announce Second Quarter 2019 Financial Results GlobeNewswire
Jul-10-19 11:57AM  Analyst: CytomX Therapeutics Validated By AbbVie Decision Benzinga
Jul-09-19 08:00AM  CytomX Therapeutics Announces Second Target Selection and Program Initiation with AbbVie Under Ongoing, Multi-Program Strategic Oncology Collaboration GlobeNewswire +9.32%
Jun-29-19 08:09AM  Did You Manage To Avoid CytomX Therapeutics's (NASDAQ:CTMX) Painful 51% Share Price Drop? Simply Wall St.
Jun-19-19 03:30PM  Heres What Hedge Funds Think About CytomX Therapeutics, Inc. (CTMX) Insider Monkey
Jun-01-19 09:00AM  CytomX Therapeutics Provides Update on Anti-PD-L1 Probody CX-072 at 2019 ASCO Annual Meeting GlobeNewswire
May-28-19 08:00AM  CytomX Therapeutics to Present at Upcoming Healthcare Conferences GlobeNewswire
May-22-19 12:57PM  Edited Transcript of CTMX earnings conference call or presentation 9-May-19 9:00pm GMT Thomson Reuters StreetEvents
May-15-19 05:20PM  CytomX Therapeutics Announces Presentations at 2019 ASCO Annual Meeting GlobeNewswire
May-13-19 01:00PM  CytomX Therapeutics, Inc. (CTMX) Q1 2019 Earnings Call Transcript Motley Fool
May-09-19 07:32PM  Were Hedge Funds Right About Dumping CytomX Therapeutics, Inc. (CTMX)? Insider Monkey
05:35PM  CytomX Therapeutics (CTMX) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:32PM  CytomX Therapeutics: 1Q Earnings Snapshot Associated Press
04:10PM  CytomX Therapeutics Announces First Quarter 2019 Financial Results GlobeNewswire
May-08-19 08:29AM  Edited Transcript of CTMX earnings conference call or presentation 6-Nov-18 10:00pm GMT Thomson Reuters StreetEvents
May-07-19 08:00AM  CytomX Therapeutics to Present at the Bank of America Merrill Lynch 2019 Health Care Conference GlobeNewswire
May-02-19 08:00AM  CytomX Therapeutics to Announce First Quarter 2019 Financial Results GlobeNewswire +5.78%
May-01-19 10:33AM  Analysts Estimate CytomX Therapeutics (CTMX) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-23-19 06:00AM  Long-Term "GameChangers" in Biotech MoneyShow +5.04%
Apr-22-19 04:05PM  CytomX Therapeutics Appoints Elaine V. Jones, Ph.D., to Board of Directors GlobeNewswire
Apr-11-19 01:19PM  What Kind Of Investor Owns Most Of CytomX Therapeutics, Inc. (NASDAQ:CTMX)? Simply Wall St.
Apr-05-19 03:04PM  Consider These 3 Falling Knives GuruFocus.com
Apr-02-19 08:00AM  AACR 2019 Presentations Highlight CX-2009, a First-In-Class Probody Drug Conjugate Targeting Novel Tumor Antigen, CD166 GlobeNewswire
Mar-26-19 07:36AM  The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs Benzinga
Mar-25-19 04:05PM  CytomX Therapeutics Announces Transition of Chief Financial Officer GlobeNewswire
Mar-06-19 08:25AM  Have Insiders Been Buying CytomX Therapeutics, Inc. (NASDAQ:CTMX) Shares? Simply Wall St. -8.43%
Mar-05-19 04:05PM  CytomX to Present at Upcoming Healthcare Conferences GlobeNewswire
Mar-03-19 02:30AM  Edited Transcript of CTMX earnings conference call or presentation 27-Feb-19 10:00pm GMT Thomson Reuters StreetEvents
Feb-27-19 05:11PM  CytomX Therapeutics Announces Presentations at the American Association for Cancer Research Annual Meeting 2019 GlobeNewswire
04:08PM  CytomX Therapeutics Announces Full-Year 2018 Financial Results GlobeNewswire
Feb-26-19 05:28PM  Big Pharma trims projects and a potential $1 billion in payments from collaboration with small Peninsula biotech American City Business Journals -31.47%
07:30AM  CytomX Therapeutics 2019 Research and Development Day Highlights Clinical Data from Lead Programs and the Broad Potential of Probody Therapeutic Platform GlobeNewswire
Feb-20-19 10:31AM  Analysts Estimate CytomX Therapeutics (CTMX) to Report a Decline in Earnings: What to Look Out for Zacks
07:25AM  Analysis: Positioning to Benefit within Jacobs Engineering Group, Ares Capital, CytomX Therapeutics, FuelCell Energy, Timken, and Farmland Partners Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Feb-14-19 04:02PM  CytomX Therapeutics to Announce Full-Year 2018 Financial Results and Host Webcast Conference Call GlobeNewswire
Feb-05-19 08:00AM  CytomX Therapeutics Announces Senior Management Appointments GlobeNewswire
Jan-30-19 08:00AM  CytomX Therapeutics to Host Research and Development Day on February 26, 2019 GlobeNewswire
Jan-22-19 11:14AM  Are CytomX Therapeutics, Inc.s (NASDAQ:CTMX) Interest Costs Too High? Simply Wall St.
Jan-16-19 09:03AM  CytomX Therapeutics Shares March Higher, Can It Continue? Zacks
Jan-07-19 08:00AM  CytomX Therapeutics Announces Technology Acquisition From Agensys, Inc., an Affiliate of Astellas Pharma Inc. GlobeNewswire
Dec-20-18 08:00AM  CytomX Therapeutics Announces Changes to its Board of Directors GlobeNewswire
Dec-17-18 01:44AM  Is CytomX Therapeutics, Inc. (CTMX) A Good Stock To Buy? Insider Monkey
Dec-14-18 02:28PM  Goldman Sachs Takes Action on Pharma Stocks GuruFocus.com
Nov-27-18 08:10AM  Consolidated Research: 2018 Summary Expectations for CarGurus, ARMOUR Residential REIT, Braskem S.A, HCI Group, Kimball Electronics, and CytomX Therapeutics Fundamental Analysis, Key Performance Indications GlobeNewswire
Nov-20-18 02:45PM  Should You Worry About CytomX Therapeutics Incs (NASDAQ:CTMX) CEO Pay? Simply Wall St.
Nov-09-18 08:00AM  CytomX Therapeutics Presents CX-072 Clinical Translational Data at 2018 SITC Annual Meeting GlobeNewswire -8.26%
Nov-07-18 08:00AM  CytomX to Present at the Jefferies 2018 London Healthcare Conference GlobeNewswire +25.10%
Nov-06-18 06:00PM  CytomX Therapeutics (CTMX) Reports Q3 Loss, Lags Revenue Estimates Zacks -8.80%
04:58PM  CytomX Therapeutics: 3Q Earnings Snapshot Associated Press
04:05PM  CytomX Therapeutics Announces Third Quarter 2018 Financial Results GlobeNewswire
08:13AM  CytomX Therapeutics Announces CX-072 Clinical Presentations at 2018 SITC Annual Meeting GlobeNewswire
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops a novel class of investigational antibody therapeutics based on its Probody technology platform for the treatment of cancer. Its product candidates in clinical stage include CX-072, a Probody therapeutic targeting programmed cell death ligand 1 immuno-oncology target; CX-2009, a Probody drug conjugate (PDC) against CD166 novel drug target; BMS-986249, a CTLA-4 Probody therapeutic drug; CX-2029, a PDC targeting CD71; and CX-188, a Probody therapeutic targeting PD-1 anti-cancer target. The company has strategic collaborations with AbbVie Ireland Unlimited Company, Amgen, Inc., Bristol-Myers Squibb Company, ImmunoGen, Inc., and Pfizer Inc. to develop Probody therapeutics. CytomX Therapeutics, Inc. was founded in 2008 and is headquartered in South San Francisco, California.